ZA200308916B - Process for the preparation of prostaglandins and analogues thereof - Google Patents

Process for the preparation of prostaglandins and analogues thereof

Info

Publication number
ZA200308916B
ZA200308916B ZA200308916A ZA200308916A ZA200308916B ZA 200308916 B ZA200308916 B ZA 200308916B ZA 200308916 A ZA200308916 A ZA 200308916A ZA 200308916 A ZA200308916 A ZA 200308916A ZA 200308916 B ZA200308916 B ZA 200308916B
Authority
ZA
South Africa
Prior art keywords
prostaglandins
analogues
preparation
Prior art date
Application number
ZA200308916A
Other languages
English (en)
Inventor
Greenwood Alan Kenneth
Thompson David George
Mchattie Derek
Clissold Derek Wyndham
Original Assignee
Resolution Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resolution Chemicals Ltd filed Critical Resolution Chemicals Ltd
Publication of ZA200308916B publication Critical patent/ZA200308916B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F295/00—Macromolecular compounds obtained by polymerisation using successively different catalyst types without deactivating the intermediate polymer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200308916A 2001-05-24 2003-11-14 Process for the preparation of prostaglandins and analogues thereof ZA200308916B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0112699.4A GB0112699D0 (en) 2001-05-24 2001-05-24 Process for the preparation of prostglandins and analogues thereof

Publications (1)

Publication Number Publication Date
ZA200308916B true ZA200308916B (en) 2007-11-28

Family

ID=9915243

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200308916A ZA200308916B (en) 2001-05-24 2003-11-14 Process for the preparation of prostaglandins and analogues thereof

Country Status (15)

Country Link
US (3) US20040249172A1 (enExample)
EP (2) EP2311820A1 (enExample)
JP (2) JP4475943B2 (enExample)
CN (2) CN1301986C (enExample)
AU (1) AU2002321396B2 (enExample)
BR (1) BR0209984A (enExample)
CA (1) CA2448088A1 (enExample)
GB (1) GB0112699D0 (enExample)
HU (1) HUP0400047A3 (enExample)
IL (1) IL159030A0 (enExample)
NO (1) NO329883B1 (enExample)
NZ (1) NZ529634A (enExample)
SK (1) SK14362003A3 (enExample)
WO (1) WO2002096898A2 (enExample)
ZA (1) ZA200308916B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0112699D0 (en) * 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
US7321057B2 (en) * 2004-08-02 2008-01-22 R-Tech Ueno, Ltd. Method for manufacturing prostaglandin analogue
PL212658B1 (pl) * 2005-04-18 2012-11-30 Inst Farmaceutyczny Sposób otrzymywania pochodnych 13,14-dihydro-PGF<sub>2</sub><sub>α</sub>
US20090287003A1 (en) * 2005-09-29 2009-11-19 Jiang Xing Chen Process for the production of intermediates for making prostaglandin derivatives such as latanaprost, travaprost, and bimatoprost
US7511168B2 (en) 2006-01-18 2009-03-31 Shih-Yi Wei Processes and intermediates for the preparations of prostaglandins
US8546114B2 (en) 2006-01-18 2013-10-01 Chirogate International Inc. Processes for the preparation of optically active cyclopentenones and cyclopentenones prepared therefrom
EP2735566A1 (en) * 2006-02-07 2014-05-28 R-Tech Ueno, Ltd. Method for preparing prostaglandin derivative
JP2008037782A (ja) * 2006-08-04 2008-02-21 Daiichi Fine Chemical Co Ltd プロスタグランジン誘導体の製造方法
US7642370B2 (en) * 2006-08-07 2010-01-05 Daiichi Fine Chemical Co., Ltd. Method for preparing prostaglandin derivative
US20090233830A1 (en) * 2008-03-14 2009-09-17 Penny Sue Dirr Automatic detergent dishwashing composition
EP2135860A1 (en) 2008-06-20 2009-12-23 Sandoz AG Improved process for the production of bimatoprost
EP2143712A1 (en) 2008-07-10 2010-01-13 Sandoz AG Improved Process for the Production of Prostaglandins and Prostaglandin Analogs
IT1392492B1 (it) * 2008-12-24 2012-03-09 Ind Chimica Srl Processo per la purificazione del latanoprost, analogo sintetico della prostaglandina pgf2alfa.
KR101045935B1 (ko) * 2009-03-11 2011-07-01 연성정밀화학(주) 프로스타글란딘 유도체의 제조방법
US8519178B2 (en) * 2009-06-22 2013-08-27 Johnson Matthey Public Limited Company Method for the purification of prostaglandins
CA2777290C (en) * 2009-10-16 2016-06-28 Cayman Chemical Company, Incorporated Process for the preparation of f-series prostaglandins
WO2011055377A1 (en) * 2009-11-05 2011-05-12 Biocon Limited A novel process for the preparation of prostaglandins and intermediates thereof
WO2011095990A2 (en) 2010-02-03 2011-08-11 Fdc Limited Process for the purification of prostaglandins and analogues thereof
EP2495235B1 (en) 2011-03-04 2015-08-05 Newchem S.p.A. Process for the synthesis of prostaglandins and intermediates thereof
HU231203B1 (hu) * 2011-12-21 2021-10-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás travoprost előállítására
TWI435752B (zh) * 2012-08-15 2014-05-01 Everlight Chem Ind Corp 使用製備型高效液相層析儀純化含氟之前列腺素之方法
US9115109B2 (en) 2013-08-15 2015-08-25 Chirogate International Inc. Processes and intermediates for the preparations of isomer free prostaglandins
HU231214B1 (hu) 2014-03-13 2021-11-29 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás nagytisztaságú prosztaglandinok előállítására
CN104513186B (zh) * 2015-01-13 2016-10-05 宁波第二激素厂 一种光学纯的右旋氯前列醇钠的制备方法
HU231175B1 (hu) * 2015-12-04 2021-06-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Tetszőleges, előre meghatározott minőségű Latanoprostene bunod előállítása gravitációs kromatográfiával
EP3950672A4 (en) * 2019-03-27 2023-01-11 Kyowa Pharma Chemical Co., Ltd. PROCESS FOR PRODUCTION OF PROSTAGLANDIN
CN112608294B (zh) * 2020-12-16 2021-10-26 西安国康瑞金制药有限公司 一种拉坦前列腺素的制备方法
WO2022138586A1 (ja) * 2020-12-23 2022-06-30 協和ファーマケミカル株式会社 幾何異性体の分離方法
CN115991691B (zh) * 2023-03-23 2023-05-16 西南交通大学 一种拉坦前列素中间体的制备方法及其用途
WO2025149165A1 (en) 2024-01-12 2025-07-17 Intervet International B.V. A PROCESS FOR PURIFICATION OF INTERMEDIATES OF PROSTAGLANDIN F2Αα COMPOUNDS AND ITS USE IN THE PREPARATION OF PROSTAGLANDIN F2α COMPOUNDS

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549688A (en) * 1967-02-16 1970-12-22 Gen Electric Process for the preparation of carboxylic acid esters
US3778450A (en) 1971-03-23 1973-12-11 Upjohn Co Certain bicyclic lactones
CA971957A (en) 1971-12-13 1975-07-29 Upjohn Company (The) PROCESS FOR PREPARING PROSTAGLANDIN E'S FROM PROSTAGLANDIN F.alpha.'S
US4100355A (en) 1972-09-15 1978-07-11 The Upjohn Company 8β,12α-PGE2 -type compounds
US3864387A (en) 1973-05-21 1975-02-04 Upjohn Co 5-Oxa phenyl-and phenoxy-substituted prostaglandin F{HD 1{301 {0 {B analogs
US3931279A (en) 1973-05-21 1976-01-06 The Upjohn Company 5-Oxa prostaglandin F2.sub.α analogs
GB1484591A (en) * 1974-04-11 1977-09-01 Ono Pharmaceutical Co Prostaglandin compositions
US4036832A (en) 1974-07-03 1977-07-19 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandins
DE2434133C2 (de) 1974-07-12 1987-03-19 Schering AG, 1000 Berlin und 4709 Bergkamen 15,15-Äthylendioxy-Prostansäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2517773A1 (de) * 1975-04-18 1976-10-28 Schering Ag Neue 11-oxo-prostaglandin-derivate und verfahren zu ihrer herstellung
US4158667A (en) * 1976-02-04 1979-06-19 The Upjohn Company 6-Keto PGF analogs
EP0059307A1 (de) 1981-02-26 1982-09-08 Grünenthal GmbH Verfahren zur Herstellung von 2-Oxabicyclo(3.3.0)octanderivaten und danach erhältliche Produkte
US4599353A (en) 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
JPS6137752A (ja) * 1984-07-30 1986-02-22 Kuraray Co Ltd 高度不飽和長鎖脂肪酸またはそのエステルの分離精製法
US4680415A (en) * 1985-06-24 1987-07-14 Hoffmann-La Roche Inc. Intermediates for 7-fluoro dihydro PGI compounds
US4943635A (en) 1987-08-27 1990-07-24 President & Fellows Of Harvard College Enantioselective reduction of ketones
EP0394263B1 (en) 1987-09-04 1994-03-16 The Upjohn Company Process for production of prostaglandin intermediates
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE420857T1 (de) 1988-09-06 2009-01-15 Pfizer Health Ab Prostaglandin-derivate zur behandlung von glaukom und ocularer hypertension
JP2855450B2 (ja) 1989-09-11 1999-02-10 小野薬品工業株式会社 プロスタグランジン誘導体の中間体の製造方法
SE9002596D0 (sv) 1990-08-08 1990-08-08 Pharmacia Ab A method for synthesis of prostaglandin derivatives
EP0472338A3 (en) * 1990-08-21 1993-05-19 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Method of manufacturing prostaglandin intermediate
JPH085873B2 (ja) 1990-08-21 1996-01-24 株式会社上野製薬応用研究所 プロスタグランジン中間体の製法
HU212570B (en) 1991-06-24 1996-08-29 Chinoin Gyogyszer Es Vegyeszet Process for producing 13,14-dihydro-15(r)-17-phenyl-18,19,20-trinor-pgf2alfa-isopropylester
US5223537A (en) * 1991-07-23 1993-06-29 Kabi Pharmacia Ab Method and composition for treatment of gastric and duodenal disorders
US5688819A (en) 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
JP3207203B2 (ja) 1992-09-30 2001-09-10 株式会社上野製薬応用研究所 α，β−不飽和ケトンの製造法
DE4323331A1 (de) 1993-07-08 1995-01-12 Schering Ag Neue bicyclische Lactone
US6184250B1 (en) * 1993-08-03 2001-02-06 Alcon Laboratories, Inc. Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
US5510383A (en) 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
NL194919C (nl) * 1993-09-07 2003-07-04 Tno Werkwijze voor het oxideren van koolhydraten.
US5545665A (en) 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US5698733A (en) 1994-09-30 1997-12-16 Alcon Laboratories, Inc. Use of 9-deoxy prostaglandin derivatives to treat glaucoma
HU223345B1 (hu) 1995-12-20 2004-08-30 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára
ATE202557T1 (de) * 1996-11-12 2001-07-15 Alcon Lab Inc 15-fluoro-prostaglandine als augendrucksenkende mittel
SE9702681D0 (sv) 1997-07-10 1997-07-10 Pharmacia & Upjohn Ab Method and composition for treatment of impotence
SE9702706D0 (sv) 1997-07-11 1997-07-11 Pharmacia & Upjohn Ab Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
WO1999012899A1 (en) 1997-09-09 1999-03-18 The Procter & Gamble Company A process for making prostaglandin f analogs
WO2000020386A1 (en) 1998-10-05 2000-04-13 Alcon Laboratories, Inc. Stannane synthesis of prostanoids
SE9900025D0 (sv) 1999-01-08 1999-01-08 Synphora Ab Method and composition for treatment of female sexual dysfunction
WO2000040246A1 (en) 1999-01-08 2000-07-13 University Of Massachusetts Detection of human immunodeficiency virus
JP3501025B2 (ja) 1999-07-15 2004-02-23 松下電器産業株式会社 電気調理器
IL134241A (en) 2000-01-27 2006-06-11 Finetech Pharmaceutical Ltd Process for the preparation of latanoprost
AU2001233286B2 (en) 2000-02-01 2006-04-06 Cayman Chemical Company, Incorporated Internal 1,15-lactones of fluprostenol and related prostaglandin F2alpha analogs and their use in the treatment of glaucoma and intraocular hypertension
WO2001067816A1 (en) 2000-03-07 2001-09-13 Daimlerchrysler Ag Skin effect heating system for a structural member
WO2001087816A1 (en) * 2000-05-15 2001-11-22 Pharmacia & Upjohn Company Process and intermediates to prepare latanoprost
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
KR100581647B1 (ko) * 2001-07-17 2006-05-22 파마시아 앤드 업존 캄파니 엘엘씨 라타노프로스트 제조를 위한 방법 및 중간체

Also Published As

Publication number Publication date
JP2010053149A (ja) 2010-03-11
US20050272877A1 (en) 2005-12-08
GB0112699D0 (en) 2001-07-18
US7268239B2 (en) 2007-09-11
AU2002321396B2 (en) 2007-10-18
JP4475943B2 (ja) 2010-06-09
CA2448088A1 (en) 2002-12-05
BR0209984A (pt) 2004-04-06
WO2002096898A3 (en) 2003-03-20
JP2005503354A (ja) 2005-02-03
NZ529634A (en) 2004-11-26
CN1533385A (zh) 2004-09-29
US7498458B2 (en) 2009-03-03
WO2002096898A2 (en) 2002-12-05
US20040249172A1 (en) 2004-12-09
NO329883B1 (no) 2011-01-17
SK14362003A3 (sk) 2004-05-04
CN101003503A (zh) 2007-07-25
HUP0400047A3 (en) 2007-05-02
EP1389198A2 (en) 2004-02-18
NO20035162D0 (no) 2003-11-20
US20050261374A1 (en) 2005-11-24
HUP0400047A2 (hu) 2004-04-28
IL159030A0 (en) 2004-05-12
EP2311820A1 (en) 2011-04-20
CN1301986C (zh) 2007-02-28

Similar Documents

Publication Publication Date Title
ZA200308916B (en) Process for the preparation of prostaglandins and analogues thereof
IL146389A0 (en) Process for the preparation of dronedarone
EP1432721A4 (en) PROCESS FOR THE PREPARATION OF REBECCAMYCIN AND ANALOGUE THEREOF
EG22992A (en) Process for the preparation of urea
IL161026A0 (en) Process for the preparation of citalopram
EP1419135A4 (en) PROCESS FOR THE PREPARATION OF TOLTERODINE
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
IL156145A0 (en) Process for the preparation of phenethylamine derivatives
IL150600A0 (en) Process for the preparation of peptides
AU8824201A (en) Process for the preparation of dinapsoline
IL158577A0 (en) Process for the preparation of azoxystrobin and analogues thereof
HUP0401577A3 (en) Process for the preparation of 2,4-didezoxyhexoses and 2,4,6-tridezoxyhexoses
HUP0203315A3 (en) Process and intermediates for the preparation of isoxazolecaroxamides and analogues
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
SI1406896T1 (sl) Stereoselektivna metoda za pripravo nukleozidnih analogov
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
PL368905A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
ZA200309774B (en) Methods for preparation and use of psorospermin analogs.
HRP20030811A2 (en) Process for the preparation of citalopram
GB0012249D0 (en) Process for the preparation of 11-oxaprostaglandins
AU2002251376A1 (en) Process for the preparation of azoxystrobin and analogues thereof
GB0113667D0 (en) Process for the preparation of endo-5-norbornene-2-ol